861 Mucosal Administration of 5-HT4 Receptor Agonists Enhances Colonic Motility, Inhibits Colonic Hypersensitivity, and Activates 5-HT Release
Jill M. Hoffman(University of California, Los Angeles), Gary M. Mawe(University of Vermont), Onesmo B. Balemba(University of Vermont), James J. Galligan(University of Arizona), Beverley Greenwood–Van Meerveld(University of Oklahoma), Karl R. Tyler(University of Oklahoma Health Sciences Center), Zhao Hong(Michigan State University), Anthony C. Johnson(University of Oklahoma Health Sciences Center)
Cited by 1
Related Papers
Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets
|Nature Reviews Gastroenterology & Hepatology|2013|1.1k
Intestinal barrier function in health and gastrointestinal disease
|Neurogastroenterology & Motility|2012|886
Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome 1 ☆
|Gastroenterology|2004|772
Activation of neuronal P2X7 receptor–pannexin-1 mediates death of enteric neurons during colitis
|Nature Medicine|2012|444
Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome
|CNS Neuroscience & Therapeutics|2015|386